| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |